Vorasidenib Maintenance for IDH Mutant Astrocytoma
Conditions
IDH-mutant Grade 2 or 3 Astrocytoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medical University of Innsbruck, Innsbruck, Austria
Kepler University Hospital - Neuromed campus, Linz, Austria
Medical University of Vienna, Vienna, Austria
Universitair Ziekenhuis Brussel, Brussels, Belgium
Ghent University Hospital, Ghent, Belgium
U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium
Masaryk Memorial Cancer Institute, Brno, Czechia
Universitary hospital Bordeaux France, Bordeaux, France
CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon, France
Marseille APHM, Marseille, France
Assistance Publique Hopitaux de Paris APHP - Sorbonne, Paris, France
Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France
Universitaskliniken Bonn, Bonn, Germany
University Hospital Frankfurt -Senckenberg Institute of Neurooncology, Frankfurt, Germany
NNeurology department heidelberg, Heidelberg, Germany
Mannheim University Hospital, Mannheim, Germany
Universitaetsklinikum Regensburg, Regensburg, Germany
Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche - AUSL di Bologna, Bologna, Italy
Veneto Institute of Oncology, Padova, Italy
Sapienza University, Roma, Italy
AOU Citta della Salute e della Scienza di Torino, Torino, Italy
Amsterdam UMC location VUMC, Amsterdam, Netherlands
Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
Erasmus MC, Rotterdam, Netherlands
Hospital de Sant Pau i La Santa Creu, Barcelona, Spain
Vall de Hebron Hospital, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
University Hospital Basel, Basel, Switzerland
University Hospital Zurich, Zurich, Switzerland
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom
Royal Marsden Hospital, Surrey Quays, United Kingdom
Study leads
Matthias Preusser
Study Chair
Universitaetsklinikum Wien - AKH uniklinieken, Vienna, Austria.
Marjolein Geurts
Study Chair
Brain Tumour Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.